Jazz Pharmaceuticals Acquires Chimerix for $935 Million, Paving the Way for Innovative Brain Cancer Treatment March 6, 2025
Jazz Pharmaceuticals to Acquire Chimerix for $935 Million, Paving the Way for Promising Brain Cancer Treatment March 5, 2025
Jazz Pharmaceuticals Aims High: $935 Million Acquisition of Chimerix to Enhance Oncology Portfolio with Promising Brain Cancer Treatment March 5, 2025
Sofinnova Partners Secures €1.2 Billion to Propel Life Sciences Investment and Innovation March 5, 2025
Sofinnova Partners Raises €1.2 Billion to Transform Life Sciences and Healthcare Investments March 5, 2025
Sofinnova Partners Secures €1.2 Billion to Propel Healthcare Innovations in Challenging Investment Landscape March 4, 2025
Sofinnova Partners Secures €1.2 Billion to Drive Innovation in Healthcare and Life Sciences March 4, 2025
Callio Therapeutics Launches with $187 Million to Pioneer Multi-Payload Antibody-Drug Conjugates for Cancer Treatment March 4, 2025
